BCL2 and Hepatic fibrosis: The Bcl-2/Bax ratio—a key indicator for assessing apoptotic propensity [49]—has been validated in liver fibrosis models, where tannic acid A inhibits hepatocyte apoptosis by elevating this ratio [50].